BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29358577)

  • 1. TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer.
    Lin ZR; Wang MY; He SY; Cai ZM; Huang WR
    Cell Death Dis; 2018 Jan; 9(2):72. PubMed ID: 29358577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F1 promotes cell cycle progression by stabilizing spindle fiber in colorectal cancer cells.
    Fang Z; Lin M; Chen S; Liu H; Zhu M; Hu Y; Han S; Wang Y; Sun L; Zhu F; Xu C; Gong C
    Cell Mol Biol Lett; 2022 Oct; 27(1):90. PubMed ID: 36221072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of TACC3 is correlated with tumor aggressiveness and poor prognosis in prostate cancer.
    Li Q; Ye L; Guo W; Wang M; Huang S; Peng X
    Biochem Biophys Res Commun; 2017 May; 486(4):872-878. PubMed ID: 28336437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63α protein up-regulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion.
    Jin H; Xie Q; Guo X; Xu J; Wang A; Li J; Zhu J; Wu XR; Huang H; Huang C
    J Biol Chem; 2017 Sep; 292(38):15952-15963. PubMed ID: 28794159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
    Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kim HH; Kwak C
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer.
    Lee SR; Roh YG; Kim SK; Lee JS; Seol SY; Lee HH; Kim WT; Kim WJ; Heo J; Cha HJ; Kang TH; Chung JW; Chu IS; Leem SH
    Clin Cancer Res; 2015 Dec; 21(23):5391-403. PubMed ID: 26268246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1.
    Xiong Z; Ye L; Zhenyu H; Li F; Xiong Y; Lin C; Wu X; Deng G; Shi W; Song L; Yuan Z; Wang X
    Mol Oncol; 2018 Jun; 12(6):896-912. PubMed ID: 29633513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.
    Zhou DS; Wang HB; Zhou ZG; Zhang YJ; Zhong Q; Xu L; Huang YH; Yeung SC; Chen MS; Zeng MS
    Oncotarget; 2015 Sep; 6(27):24163-77. PubMed ID: 26219398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.
    Nahm JH; Kim H; Lee H; Cho JY; Choi YR; Yoon YS; Han HS; Park YN
    Tumour Biol; 2016 Jan; 37(1):393-403. PubMed ID: 26219896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer.
    Jiang F; Kuang B; Que Y; Lin Z; Yuan L; Xiao W; Peng R; Zhang X; Zhang X
    Oncol Rep; 2016 Jan; 35(1):436-46. PubMed ID: 26531241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR3-TACC3 cancer gene fusions cause mitotic defects by removal of endogenous TACC3 from the mitotic spindle.
    Sarkar S; Ryan EL; Royle SJ
    Open Biol; 2017 Aug; 7(8):. PubMed ID: 28855393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
    Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis.
    Du Y; Liu L; Wang C; Kuang B; Yan S; Zhou A; Wen C; Chen J; Wu Y; Yang X; Feng G; Liu B; Iwamoto A; Zeng M; Wang J; Zhang X; Liu H
    Oncotarget; 2016 Jul; 7(27):41885-41897. PubMed ID: 27248823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-325 Is a Potential Biomarker and Tumor Regulator in Human Bladder Cancer.
    Lin T; Zhou S; Gao H; Li Y; Sun L
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818790536. PubMed ID: 30176759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancer.
    Liu A; Zeng S; Lu X; Xiong Q; Xue Y; Tong L; Xu W; Sun Y; Zhang Z; Xu C
    Int J Biol Macromol; 2019 Feb; 123():322-334. PubMed ID: 30414902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of transforming acidic coiled coil-containing protein 3 strongly correlates with aggressive characteristics and poor prognosis of gastric cancer.
    Yun M; Rong J; Lin ZR; He YL; Zhang JX; Peng ZW; Tang LQ; Zeng MS; Zhong Q; Ye S
    Oncol Rep; 2015 Sep; 34(3):1397-405. PubMed ID: 26133271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of TACC3 in Breast Cancer Associates With Poor Prognosis.
    Song H; Liu C; Shen N; Yi P; Dong F; Li X; Zhang N; Huang T
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):113-119. PubMed ID: 27258563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.
    Kim K; Cho YM; Park BH; Lee JL; Ro JY; Go H; Shim JW
    Int J Clin Exp Pathol; 2015; 8(1):743-50. PubMed ID: 25755769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Transforming Acidic Coiled Coil‑Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma.
    Sun Y; Tian Y; Wang GZ; Zhao SH; Han B; Li YL; Jiang CL
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28273854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
    Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
    Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.